前列腺腺癌

qián liè xiàn xiàn ái
  • prostate adenocarcinoma
前列腺腺癌前列腺腺癌
  1. 混合型p504s/34βE12/p63抗体在前列腺腺癌诊断中的应用价值

    Value of p504s / 34 β E12 / p63 Cocktail in diagnosis of prostate adenocarcinoma

  2. 试一试翻译。部分萎缩通常与前列腺腺癌很相似。

    Partial atrophy is the most common mimicker of prostate adenocarcinoma .

  3. VEGF在前列腺腺癌和前列腺增生组织中的表达及其意义

    Expression of vascular endothelial growth factor ( vegf ) in Chinese prostate cancer and benign prostatic hyperplasia

  4. 不同组织级和细胞级的前列腺腺癌中EGF、EGFR、PCNA的表达未见明显差异(P>0.05)。

    There were no significant difference between different tissue and cell types in the expression of EGF , EGFR and PCNA ( P > 0.05 ) .

  5. 结果:62例前列腺腺癌中,EGF阳性39例,EGFR阳性45例,细胞增殖活跃21例。

    Results : In 62 patients with prostatic cancer , the positive expression of EGF 、 EGFR and PCNA were 39 、 45 、 21 cases respectively .

  6. 结论:P504s诊断前列腺腺癌具有较强的敏感性(95.5%)和特异性(99.2%),在前列腺良、恶性肿瘤的鉴别诊断中有重要参考价值。

    Conclusions : P504s is an useful marker for microscopic diagnosis and differential diagnosis of prostatic neoplasms with the good sensitivity ( 95.5 % ) and specificity ( 99.2 % ) .

  7. 前列腺腺癌的分级是根据肿瘤的浸润程度而定的。

    Staging of prostatic adenocarcinoma is based upon how extensive the tumor is .

  8. 背景和目的:前列腺腺癌是泌尿生殖系统的主要恶性肿瘤之一。

    Background : Prostate adenocarcinoma is one of the major malignancies of the genitourinary system .

  9. 152例前列腺腺癌的诊断分析

    Diagnosis of prostate adenocarcinoma in 152 cases

  10. 前列腺腺癌通过淋巴道转移到肺,肺叶之间和胸膜下的淋巴管中都可见癌细胞。

    Prostatic adenocarcinoma is famous for metastasizing to the lungs in a " lymphangitic " pattern in which streaks of tumor appear between lung lobules and beneath the pleura in lymphatic spaces .

  11. 前列腺泡沫状腺癌7例报道

    Prostatic foamy adenocarcinoma : a report of 7 cases

  12. 侵及前列腺的结直肠腺癌&附5例报告

    Cases of colorectal adenocarcinoma involving the prostate

  13. 前列腺基底细胞腺癌

    Basal cell adenocarcinoma of prostate

  14. 这些初步的实验结果表明这些化合物在抗癌(前列腺癌、肺腺癌、肝癌、肺癌和肠癌)及抗炎方面具有潜在的应用价值。

    These preliminary results are promising and some of these compounds may be potential candidates for new anticancer ( prostate cancer , lung cancer , liver cancer , lung cancer , intestinal cancer ) and antiinflammatory agents .

  15. 方法运用聚合酶链反应-单链构象多态性分析法(PCR-SSCP),对18例良性前列腺增生、37例前列腺腺癌组织进行雄激素受体基因CAG微卫星数量测定。

    Methods The number of CAG microsatellites in exon 1 of the AR gene was measured in tissues of 18 cases of BPH and 37 of PC by polymerase chain reaction single strand conformation polymophism ( PCR SSCP ) analysis .

  16. 高分子量细胞角蛋白及前列腺特异性抗原在前列腺腺癌中的表达和意义

    Expression of high molecular weight cytokeratin and prostate specific antigen in prostate adenocarcinoma and its value

  17. 雌激素受体β在正常前列腺、良性前列腺增生症和前列腺腺癌中的表达

    Estrogen receptors β in the normal 、 benign prostatic hyperplasia and prostate cancer

  18. 目的探讨前列腺偶发癌与前列腺增生(BPH)及前列腺腺癌的关系及鉴别诊断。

    Objective To discuss the relationship between IDPC and BPH and that between IDPC and prostate adenocarcinoma , and the diagnosis and identification of IDPC .